National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

99mTc-DTPA-mannosyl-dextran
A radiolabeled macromolecule consisting of the chelating agent diethylenetriamine pentaacetic acid (DTPA) and mannose each attached to a dextran backbone and labeled with metastable technetiumTc-99 (Tc-99m), with mannose binding and radioisotopic activities. Upon injection, the mannose moiety of 99mTc-DTPA-mannosyl-dextran binds to mannose-binding protein (MBP). As MBPs reside on the surface of dendritic cells and macrophages, this gamma-emitting macromolecule tends to accumulate in lymphatic tissue where it may be imaged using gamma scintigraphy. This agent exhibits rapid clearance from the injection site, rapid uptake and high retention within the first draining lymph node, and low uptake by the remaining lymph nodes. MBP is a C-type lectin that binds mannose or fucose carbohydrate residues, such as those found on the surfaces of many pathiogens, and once bound activates the complement system. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:99mTc-diethylenetriamine pentaacetic acid-mannosyl-dextran
US brand name:Lymphoseek



Previous:7-cyanoquinocarcinol, 7-hydroxystaurosporine, 8-hydroxyquinoline sulfate ointment, 851B gel, 852A
Next:[18F]-labeled substance P antagonist receptor quantifier, [18F]-ML-10, [F-18]HX4, abagovomab, abarelix

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov